Chong Zhao

Author PubWeight™ 51.62‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy: long-term results of a phase 2 study. Cancer 2010 2.48
2 Long-term outcomes of early-stage nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy alone. Int J Radiat Oncol Biol Phys 2010 1.91
3 Prospective study of tailoring whole-body dual-modality [18F]fluorodeoxyglucose positron emission tomography/computed tomography with plasma Epstein-Barr virus DNA for detecting distant metastasis in endemic nasopharyngeal carcinoma at initial staging. J Clin Oncol 2013 1.81
4 The role of concurrent chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma among endemic population: a meta-analysis of the phase III randomized trials. BMC Cancer 2010 1.68
5 Results of a phase 2 study examining the effects of omitting elective neck irradiation to nodal levels IV and Vb in patients with N(0-1) nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2012 1.68
6 Effect of total dose and fraction size on survival of patients with locally recurrent nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: a phase 2, single-center, randomized controlled trial. Cancer 2014 1.44
7 Long-term treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapy. Eur J Cancer 2012 1.33
8 Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2004 1.32
9 Treatment outcomes for different subgroups of nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy. Chin J Cancer 2011 1.24
10 Postradiation nasopharyngeal necrosis in the patients with nasopharyngeal carcinoma. Head Neck 2009 1.24
11 Long-term outcomes and prognostic factors of re-irradiation for locally recurrent nasopharyngeal carcinoma using intensity-modulated radiotherapy. Clin Oncol (R Coll Radiol) 2011 1.21
12 Treatment outcomes after radiotherapy alone for patients with early-stage nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2009 1.20
13 Phase III study comparing standard radiotherapy with or without weekly oxaliplatin in treatment of locoregionally advanced nasopharyngeal carcinoma: preliminary results. J Clin Oncol 2005 1.17
14 Gambogic acid induces apoptosis in imatinib-resistant chronic myeloid leukemia cells via inducing proteasome inhibition and caspase-dependent Bcr-Abl downregulation. Clin Cancer Res 2013 1.16
15 Different clinical significance of pre- and post-treatment plasma Epstein-Barr virus DNA load in nasopharyngeal carcinoma treated with radiotherapy. Clin Oncol (R Coll Radiol) 2010 1.12
16 Outcome of fractionated stereotactic radiotherapy for 90 patients with locally persistent and recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2007 1.11
17 Association of p73 G4C14-to-A4T14 polymorphism with human papillomavirus type 16 status in squamous cell carcinoma of the head and neck in non-Hispanic whites. Cancer 2009 1.09
18 Intensity-modulated radiation therapy reduces radiation-induced trismus in patients with nasopharyngeal carcinoma: a prospective study with >5 years of follow-up. Cancer 2011 1.09
19 Association of XRCC1 polymorphisms and risk of differentiated thyroid carcinoma: a case-control analysis. Thyroid 2009 1.08
20 A randomized trial on addition of concurrent-adjuvant chemotherapy and/or accelerated fractionation for locally-advanced nasopharyngeal carcinoma. Radiother Oncol 2011 1.04
21 Gambogic acid is a tissue-specific proteasome inhibitor in vitro and in vivo. Cell Rep 2012 1.04
22 Exogenous low dose hydrogen peroxide increases hypoxia-inducible factor-1alpha protein expression and induces preconditioning protection against ischemia in primary cortical neurons. Neurosci Lett 2008 1.01
23 Clinical findings and imaging features of 67 nasopharyngeal carcinoma patients with postradiation nasopharyngeal necrosis. Chin J Cancer 2013 0.96
24 Human peritoneal mesothelial cell transformation into myofibroblasts in response to TGF-ß1 in vitro. Int J Mol Med 2010 0.95
25 Radiation response genotype and risk of differentiated thyroid cancer: a case-control analysis. Laryngoscope 2005 0.94
26 RET polymorphisms and haplotypes and risk of differentiated thyroid cancer. Laryngoscope 2005 0.92
27 Optimal waveforms design for ultra-wideband impulse radio sensors. Sensors (Basel) 2010 0.90
28 Enhanced NMDA receptor tyrosine phosphorylation and increased brain injury following neonatal hypoxia-ischemia in mice with neuronal Fyn overexpression. Neurobiol Dis 2012 0.90
29 [Prophylactic irradiation at the level Ib for nasopharyngeal carcinoma: should that be a routine?]. Nan Fang Yi Ke Da Xue Xue Bao 2011 0.88
30 [Role of 18F-FDG PET/CT in diagnosis and staging of nasopharyngeal carcinoma]. Ai Zheng 2008 0.86
31 Associations of single nucleotide polymorphisms in miR-146a, miR-196a, miR-149 and miR-499 with colorectal cancer susceptibility. Asian Pac J Cancer Prev 2014 0.85
32 Damage of nasal mucociliary movement after intensity-modulated radiation therapy of nasopharyngeal carcinoma. Chin J Cancer 2010 0.83
33 Glutathione S-transferase polymorphisms and risk of differentiated thyroid carcinomas: a case-control analysis. Arch Otolaryngol Head Neck Surg 2006 0.83
34 A prospective, randomized, multi-center trial to investigate Actovegin in prevention and treatment of acute oral mucositis caused by chemoradiotherapy for nasopharyngeal carcinoma. Radiother Oncol 2010 0.83
35 [Short-term efficacy of endoscopy-guided debridement on radiation-related nasopharyngeal necrosis in 20 nasopharyngeal carcinoma patients after radiotherapy]. Ai Zheng 2008 0.80
36 [Evaluation of CT, MRI and PET-CT in detecting retropharyngeal lymph node metastasis in nasopharyngeal carcinoma]. Ai Zheng 2006 0.80
37 Adefovir dipivoxil modulates cytokine expression in Th1/Th2 cells in patients with chronic hepatitis B. Mol Med Rep 2011 0.80
38 [Staging 915 cases of nasopharyngeal carcinoma after simple radical radiotherapy--checkout of Fuzhou staging system (1992)]. Ai Zheng 2005 0.80
39 X-ray repair cross-complementing group 1 (XRCC1) single-nucleotide polymorphisms and the risk of salivary gland carcinomas. Cancer 2007 0.80
40 CT-guided needle biopsy through mandibular area for the diagnosis of nasopharyngeal carcinoma in the parapharyngeal space. Chin J Cancer 2010 0.80
41 Temporal lobe injury after re-irradiation of locally recurrent nasopharyngeal carcinoma using intensity modulated radiotherapy: clinical characteristics and prognostic factors. J Neurooncol 2014 0.80
42 [Clinical study in prophylactic use of chinese medicine to prevent chemoradiotherapy induced mucositis in nasopharyngeal carcinoma]. Ai Zheng 2003 0.79
43 Effectiveness of a Chinese hamster ovary cell derived hepatitis B vaccine in Chinese rural communities. Vaccine 2011 0.79
44 Fas single nucleotide polymorphisms and risk of thyroid and salivary gland carcinomas: a case-control analysis. Head Neck 2008 0.79
45 [Prognostic impact of plasma Epstein-Barr virus DNA concentration on distant metastasis in nasopharyngeal carcinoma]. Ai Zheng 2006 0.78
46 BCN nanotubes as highly sensitive torsional electromechanical transducers. Nano Lett 2014 0.78
47 [The effect of overall treatment time on local control in nasopharyngeal carcinoma patients treated with intensity modulated radiation therapy]. Zhonghua Yi Xue Za Zhi 2011 0.78
48 [Retrospective analysis of 934 nasopharyngeal carcinoma patients treated with conventional external beam radiotherapy alone]. Zhonghua Zhong Liu Za Zhi 2005 0.78
49 [Phase II clinical trial of h-R3 combined radiotherapy for locoregionally advanced nasopharyngeal carcinoma]. Ai Zheng 2007 0.77
50 [Radiation-induced temporomandibular joint damage in nasopharyngeal carcinoma patients after intensity-modulated radiotherapy]. Ai Zheng 2007 0.77
51 Functional polymorphisms of matrix metalloproteinase-9 and survival in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy. Med Oncol 2013 0.76
52 Genetic variations in radiation and chemotherapy drug action pathways and survival in locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy. PLoS One 2013 0.76
53 Expression of matrix metalloproteinase-12 in aortic dissection. BMC Cardiovasc Disord 2013 0.75
54 [Bioavailability of cadmium in seawater to Paralichthys olivaceus]. Ying Yong Sheng Tai Xue Bao 2005 0.75
55 [Contamination level of aflatoxin B1 in lotus seeds rapid screening by indirect competitive ELISA method]. Zhongguo Zhong Yao Za Zhi 2015 0.75
56 [Changes of hypoxia in primary lesion of nasopharyngeal carcinoma during the treatment course and the clinical value thereof]. Zhonghua Yi Xue Za Zhi 2007 0.75
57 [Clinical application of 99mTc-HL91 hypoxia imaging in nasopharyngeal carcinoma]. Ai Zheng 2006 0.75
58 Comprehensive treatment of squamous cell cancer of head and neck: Chinese expert consensus 2013. Future Oncol 2014 0.75
59 [Correlation between the kinetics of plasma EBV DNA levels and clinical response during treatment in patients with nasopharyngeal carcinoma]. Ai Zheng 2002 0.75
60 [Intensity modulated radiation therapy for 49 patients with recurrent nasopharyngeal carcinoma]. Zhonghua Zhong Liu Za Zhi 2003 0.75
61 [Prognostic analysis of patients with cerebral glioma treated with radiotherapy]. Ai Zheng 2004 0.75
62 [Correlation of DNA ploidy in fresh tumor tissues to prognosis of nasopharyngeal carcinoma]. Ai Zheng 2007 0.75
63 [Radiologic criteria of MRI in diagnosing retropharyngeal lymph nodal metastasis of nasopharyngeal carcinoma]. Zhonghua Yi Xue Za Zhi 2006 0.75
64 A magnetoreception system constructed by a dysprosium metallofullerene and nitroxide radical. Dalton Trans 2017 0.75
65 [To repair defects of facial skin and tissue with the axial flap]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2015 0.75
66 [Design planning target volumes (PTVs) in intensity-modulated radiotherapy for nasopharyngeal carcinoma]. Ai Zheng 2007 0.75
67 [Staging 915 cases of nasopharyngeal carcinoma after simple radical radiotherapy (Part II)--Checkout of AJCC/UICC staging system (1997)]. Ai Zheng 2006 0.75
68 [Influence of patient setup error on planning risk volumes for nasopharyngeal carcinoma patients receiving intensity-modulated radiation therapy]. Ai Zheng 2008 0.75
69 [Weekly paclitaxel with concurrent intensity-modulated radiotherapy for nasopharyngeal carcinoma: outcomes of a tolerance trial]. Ai Zheng 2007 0.75
70 Molecular weight effects on the phase-change-enhanced temperature coefficient of resistance in carbon nanotube/poly(N-isopropylacrylamide) composites. Nanotechnology 2015 0.75
71 Structure and Ca2+ regulation of frog photoreceptor guanylate cyclase, ROS-GC1. Mol Cell Biochem 2003 0.75